| CYSB2400203 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-08-08 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
| JXSS1300004 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Import Drug Application | 2013-06-18 | | | Certificate Issued | 2018-05-24 | view |
| CYSB2101009 | 重组人促红素注射液(CHO细胞) | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2021-03-22 | | Beijing Four Rings Bio-Pharmaceutical Co Ltd | | | view |
| JYSB2300074 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Supplementary Application | 2023-04-26 | | | | | view |
| JYSB2200150 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Supplementary Application | 2022-08-12 | | | | | view |
| JXSL1000034 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Import Drug Application | 2010-08-04 | | Roche Pharma (Schweiz) Ltd | Certificate Issued | 2013-02-19 | view |
| J0401451 | 甲氧基聚乙二醇重组人红细胞生成素注射剂 | | Injection | Biological Products(1) | Import Drug Application | 2004-08-12 | | Shanghai Roche Pharmaceuticals Ltd Beijing | Certificate Issued | 2005-05-25 | view |
| CYSB2200215 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-08-26 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2400064 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-03-09 | | | | | view |
| CYSB2101252 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2021-11-04 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
| JYSB2200151 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Supplementary Application | 2022-08-12 | | | | | view |
| JXSB0500010 | 甲氧基聚乙二醇重组人红细胞生成素注射剂 | | Injection | Biological Products | Supplementary Application | 2005-03-22 | | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2005-08-26 | view |
| CYSB2101258 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2021-11-04 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
| CYSB2400178 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-07-09 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2101015 | 重组人促红素注射液(CHO细胞) | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2021-03-22 | | Beijing Four Rings Bio-Pharmaceutical Co Ltd | | | view |
| JYSZ2300005 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | License Renew | 2023-01-29 | | | | | view |
| CYSB2200100 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-03-30 | | Kexing Biopharm Co Ltd | | | view |
| CYSB2400204 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-08-08 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
| JXSS1300008 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Import Drug Application | 2013-06-18 | | | Certificate Issued | 2018-05-24 | view |
| CYSB2101013 | 重组人促红素注射液(CHO细胞) | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2021-03-22 | | Beijing Four Rings Bio-Pharmaceutical Co Ltd | | | view |
